Unknown

Dataset Information

0

Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype.


ABSTRACT: BACKGROUND:Hereditary spastic paraplegias (HSP) are neurodegenerative disorders characterized by lower limb spasticity and weakness, with or without additional symptoms. Mutations in ATP13A2, known to cause Kufor-Rakeb syndrome (KRS), have been recently implicated in HSP. METHODS:Whole-exome sequencing was done in a Canada-wide HSP cohort. RESULTS:Three additional patients with homozygous ATP13A2 mutations were identified, representing 0.7% of all HSP families. Spastic paraplegia was the predominant feature, all patients suffered from psychiatric symptoms, and one patient had developed seizures. Of the identified mutations, c.2126G>C;(p.[Arg709Thr]) is novel, c.2158G>T;(p.[Gly720Trp]) has not been reported in ATP13A2-related diseases, and c.2473_2474insAAdelC;p.[Leu825Asnfs*32]) has been previously reported in KRS but not in HSP. Structural analysis of the mutations suggested a disruptive effect, and enrichment analysis suggested the potential involvement of specific pathways. CONCLUSION:Our study suggests that in HSP patients with psychiatric symptoms, ATP13A2 mutations should be suspected, especially if they also have extrapyramidal symptoms.

SUBMITTER: Estiar MA 

PROVIDER: S-EPMC7057081 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype.

Estiar Mehrdad A MA   Leveille Etienne E   Spiegelman Dan D   Dupre Nicolas N   Trempe Jean-François JF   Rouleau Guy A GA   Gan-Or Ziv Z  

Molecular genetics & genomic medicine 20200115 3


<h4>Background</h4>Hereditary spastic paraplegias (HSP) are neurodegenerative disorders characterized by lower limb spasticity and weakness, with or without additional symptoms. Mutations in ATP13A2, known to cause Kufor-Rakeb syndrome (KRS), have been recently implicated in HSP.<h4>Methods</h4>Whole-exome sequencing was done in a Canada-wide HSP cohort.<h4>Results</h4>Three additional patients with homozygous ATP13A2 mutations were identified, representing 0.7% of all HSP families. Spastic para  ...[more]

Similar Datasets

| S-EPMC5141523 | biostudies-literature
| S-EPMC5278306 | biostudies-literature
| S-EPMC6593507 | biostudies-literature
| S-EPMC4939695 | biostudies-literature
| S-EPMC7254873 | biostudies-literature
| S-EPMC2640216 | biostudies-literature
2007-07-29 | E-GEOD-1300 | biostudies-arrayexpress
| S-EPMC7921051 | biostudies-literature
| S-EPMC2841798 | biostudies-literature
| S-EPMC7187706 | biostudies-literature